MARY MCFERREN: Open Payments
NPI 1114924404 · SHREVEPORT, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$4,362 in 275 payments from 31 companies in 2025. Trend: 2023 $3,179 · 2024 $3,802 · 2025 $4,362
Food & beverage: $4,274Education: $87
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 64 | $1,010 |
| Neurocrine BioSciences, Inc. | 23 | $358 |
| ACADIA Pharmaceuticals Inc | 51 | $311 |
| PFIZER INC. | 15 | $262 |
| Biogen, Inc. | 10 | $260 |
| Genentech USA, Inc. | 10 | $244 |
| MDD US Operations, LLC | 9 | $202 |
| Teva Pharmaceuticals USA, Inc. | 10 | $202 |
| Otsuka America Pharmaceutical, Inc. | 10 | $191 |
| Novartis Pharmaceuticals Corporation | 14 | $151 |
Products named: BOTOX, QULIPTA, INGREZZA, NUPLAZID, REXULTI, NURTEC ODT, Ocrevus Zunovo, Leqembi.
Industry payments across LA — which companies pay providers there.
